Beom-jun D. Kim
Seoul, Republic of Korea
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 123 publications
Romosozumab and Cardiovascular Safety: Bridging the Gap between Clinical Trials and Real-World Evidence.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: May 04, 2026
Nationwide Big Data Studies of Endocrine Diseases Using the Korean National Health Information Database: Research Trends and Standardization of Operational Definitions.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: February 02, 2026
Elevated Serum CXCL9 Levels Are Associated with Greater Frailty Risk in Older Women.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: November 11, 2025
Medication-related osteonecrosis of the jaw: an evidence-based 2025 position statement from a Korean multidisciplinary task force.
Journal: Journal of the Korean Association of Oral and Maxillofacial Surgeons
Published: October 03, 2025
Medication-Related Osteonecrosis of the Jaw: An Evidence-Based 2025 Position Statement from a Korean Multidisciplinary Task Force.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: October 03, 2025
Myosteatosis: Epidemiological Insights, Functional Decline, and Diagnostic Advances.
Journal: Current obesity reports
Published: September 23, 2025
Sarcopenia and Muscle Aging: Updated Insights into Molecular Mechanisms and Translational Therapeutics.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: September 11, 2025
Establishing Blood-Based Biomarkers for Sarcopenia: Current Challenges and Future Directions.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: August 07, 2025
Higher Circulating Kynurenine Levels Linked to Higher Risk of Sarcopenia in Older Adults: A Cohort Study and UK Biobank Analysis.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: August 01, 2025
Efficacy comparison of 6-month romosozumab plus denosumab versus 12-month romosozumab in Koreans.
Journal: European journal of endocrinology
Published: July 06, 2025
Elevated Circulating Ceramides 18:0 and 24:1 as a Risk Factor for Sarcopenia: In Vitro, Animal, and Clinical Evidence.
Journal: Journal of cachexia, sarcopenia and muscle
Published: June 25, 2025
Low Serum 25-Hydroxyvitamin D as a Risk Factor for Frailty in Community-Dwelling Older Men: A Korean Nationwide Study.
Journal: Endocrinology and metabolism (Seoul, Korea)
Published: May 19, 2025
Last Updated: 09/26/2026